
-
From Chicago to Chiclayo: Peruvian town hails adoptive son and pope
-
Ivorian women fight FGM with reconstructive surgery
-
Pedersen wins opening stage of Giro d'Italia in Albania
-
Stocks mixed despite hopes for US-China tariff talks
-
US, Swiss agree to speed up tariff talks
-
Trump floats cutting China tariffs to 80% ahead of trade talks
-
Pedersen wins opening stage of Giro d'Italia
-
Marc Marquez sets Le Mans lap record in French MotoGP practice
-
Jungle music: Chimp drumming reveals building blocks of human rhythm
-
Guardiola tells Man City stars to question their hunger after troubled season
-
Putin, Xi, Steven Seagal and missiles: Russia's Red Square parade
-
Trump suggests lower 80% China tariff ahead of Geneva trade talks
-
Arteta wants Arsenal to use Liverpool guard of honour as title fuel
-
Stocks lifted by hopes for US-China talks
-
Putin hails troops in Ukraine as allies attend WWII parade
-
UK, northern European nations support Ukraine 30-day ceasefire: Norway PM
-
Activists hold 'die-in' protest at Soviet monument in Warsaw
-
Trump suggests lower China tariff, says 80% 'seems right!'
-
Alonso confirms exit from Leverkusen at end of season
-
Maresca ready for Chelsea's 'huge' Newcastle test
-
Alcaraz, Sabalenka cruise to wins at the Italian Open
-
Swiss seize window of opportunity on Trump tariffs
-
Amorim admits Man Utd 'problems' despite reaching Europa League final
-
New Pope Leo XIV has mixed record on abuse: campaigners
-
Xabi Alonso confirms exit from Bayer Leverkusen at season's end
-
From blockades to ballots: Serbian students confront government
-
Kyiv's EU allies endorse tribunal to try Russian leaders
-
Two men found guilty of chopping down iconic UK tree
-
Tennis, Twitter and marinated fish: Things to know about Pope Leo
-
Liverpool's Salah voted Football Writers' Player of the Year
-
Pakistan says India has brought neighbours 'closer to major conflict'
-
Stocks lifted by hopes for US-China talks after UK deal
-
Putin hails troops fighting in Ukraine as foreign leaders attend parade
-
Howe urges Newcastle to fulfil Champions League expectation
-
Weary border residents in Indian Kashmir struggle to survive
-
Leo XIV says Church must fight 'lack of faith' in first mass as pope
-
Liverpool boss Slot fears replacing Alexander-Arnold will be a tough task
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
-
India says repulsed fresh Pakistan attacks as death toll climbs
-
Japan's Panasonic targets 10,000 job cuts worldwide
-
Putin evokes WWII victory to rally Russia behind Ukraine offensive
-
China exports beat forecasts ahead of US tariff talks
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
-
German lender Commerzbank's profits jump as it fends off UniCredit
-
Rare bone-eroding disease ruining lives in Kenya's poorest county

CeCors Announces Leadership Transition - Michael Maher, Distinguished Veteran and Leader, Named Interim CEO
announces the appointment of Michael Maher as Interim Chief Executive Officer, effective immediately. Mr. Maher brings extensive leadership experience and a proven track record in driving operational efficiencies, compliance excellence and fiscal responsibility, positioning CeCors for sustainable growth.
"We are excited to welcome Michael Maher to lead CeCors into its next phase of growth," said Sukhinder Kalsi, CeCors CFO and board member. "Michael's distinguished background in the U.S. Navy, Federal Bureau of Investigation ("FBI"), Department of Justice and his entrepreneurial success make him uniquely qualified to enhance our operations, deliver on targeted objectives, and expand shareholder value."
Mr. Maher has concurrently been appointed CEO and director of VETCOMM, CeCors' rapidly growing wholly-owned subsidiary focused on veteran claims benefits. His immediate priorities include streamlining operations, bolstering regulatory compliance, and implementing fiscal discipline to maximize value for the Company's client base and shareholders.
Michael Maher is a former Navy Nuclear Submariner, U.S. Department of Justice Special Agent of the Federal Bureau of Investigation and has held numerous executive leadership roles globally. He is an alumnus of the FBI Academy, Navy Nuclear Power School, Oxford University, and a senior executive fellow with Harvard's John F. Kennedy School of Government.
"As a Navy veteran formerly stationed here in San Diego, I am honored to lead VETCOMM's incredible team in advancing its mission to serve veterans," said Michael Maher. "My vision for CeCors extends beyond operational improvement. I aim to implement innovative strategies that ensure compliance, efficiency, and financial responsibility, while also driving expansion of our complementary subsidiaries, including PsyKey and new operating segments for VETCOMM."
Under Mr. Maher's interim leadership, CeCors will continue to focus on its core mission while exploring new business opportunities and innovative solutions to meet the evolving needs of those we serve. Mr. Maher will oversee the implementation of VETCOMM's 2025 operating agenda, building on operational protocols as the company continues to grow, ensuring best practices across all operating segments.
About CeCors, Inc.
CeCors, Inc. (CEOS) is a publicly traded company on the OTC Market, engaging in the acquisition and development of healthcare companies with a focus on military veterans' health and well-being. CEOS has acquired VETCOMM and PsyKey as wholly owned subsidiaries working toward this common goal. VETCOMM aims to bridge the gap between U.S. military veterans and their entitled access to healthcare, vocational benefits, and compensation associated with their military service by utilizing VETCOMM's proprietary tools, education, and resources to guide veterans through the complex process. PsyKey focuses on delivering health and well-being by modifying the habits of daily tea and coffee drinkers with its premium functional mushroom coffee. These are available as K-cups and ground coffee blends infused with high-quality mushrooms such as Lion's Mane, Maitake, Turkey tail, Chaga, and Cordyceps. This innovative solution promotes wellness, boosts immunity, enhances focus, and helps users relax and manage stress. CEOS is committed to the continued research, development, and support of modern-day health solutions while respecting proven traditional remedies from ancient practices.
For further information:
CeCors, Inc.
Website: www.cecorsinc.com
Email: [email protected]
Publicly traded company (OTC PINK:CEOS)
VETCOMM
Website: www.vetcomm.us
E-mail: [email protected]
Referral Program: www.vetcomm.us/referral-membership/
PsyKey Inc.
Website: www.psykeyworld.com
Email: [email protected]
Forward-Looking Statements:
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
Contact Information
Rafer Weigel
CCO, VETCOMM
[email protected]
312-914-8690


SOURCE: CeCors, Inc.
D.Moore--AMWN